Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury

Open access
Yang, Hai-Chun, Deleuze, Sebastien, Zuo, Yiqin, Potthoff, Sebastian A., Ma, Li-Jun, Fogo, Agnes B. · 2009 · Journal of the American Society of Nephrology

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists not only improve metabolic abnormalities of diabetes and consequent diabetic nephropathy, but they also protect against nondiabetic chronic kidney disease in experimental models. Here, we found that the PPAR-gamma agonist pioglitazone protected against renal injury in aging; it reduced proteinuria, improved GFR, decreased sclerosis, and alleviated cell senescence. Increased local expression of PPAR-gamma paralleled these changes. Underlying mechanisms included increased expression of klotho, decreased systemic and renal oxidative stress, and decreased mitochondrial injury. Pioglitazone also regulated p66(Shc) phosphorylation, which integrates many signaling pathways that affect mitochondrial function and longevity, by reducing protein kinase C-beta. These results suggest that PPAR-gamma agonists may benefit aging-related renal injury by improving mitochondrial function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2008111138

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 169

Metadata

Authors
Yang, H.-C., Deleuze, S., Zuo, Y., Potthoff, S. A., Ma, L.-J., & Fogo, A. B.
Venue
Journal of the American Society of Nephrology
Published
2009-11
Volume
20
Issue
11
Pages
2380-2388
ISSN
1046-6673 (ISSN-L)
OpenAlex
W2149426365
Cited by
169
References
3
FWCI
4.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury. https://app.cochat.ai/papers/10.1681/asn.2008111138
The paper
Yang, H.-C., Deleuze, S., Zuo, Y., Potthoff, S. A., Ma, L.-J., & Fogo, A. B. (2009). The PPARγ Agonist Pioglitazone Ameliorates Aging-Related Progressive Renal Injury. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2008111138

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.